Here are three things to know.
1. Levocetirizine dihydrochloride is an oral treatment used to relieve symptoms associated with perennial allergic rhinitis in children two years and under.
2. The drug can also be used to treat hives caused by an allergic reaction in adults and children six months and older.
3. Levocetirizine dihydrochloride is the therapeutic equivalent of Sanofi’s allergy drug Xyzal.
More articles on supply chain:
Viewpoint: Why healthcare needs more ‘me too’ drugs
FDA safety warning: Diabetes drug causes higher risk of foot, leg amputations
FDA approves Abon Pharma’s pediatric leukemia drug
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
